0000939767-23-000084.txt : 20230807 0000939767-23-000084.hdr.sgml : 20230807 20230807212014 ACCESSION NUMBER: 0000939767-23-000084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230803 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Senner Christopher J. CENTRAL INDEX KEY: 0001648367 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 231149074 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wk-form4_1691457604.xml FORM 4 X0508 4 2023-08-03 0 0000939767 EXELIXIS, INC. EXEL 0001648367 Senner Christopher J. C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 0 1 0 0 EVP and CFO 0 Common Stock 2023-08-03 4 M 0 60000 14.74 A 631631 D Common Stock 2023-08-03 4 S 0 60000 20.51 D 571631 D Common Stock 2023-08-04 4 M 0 60000 14.74 A 631631 D Common Stock 2023-08-04 4 S 0 60000 20.68 D 571631 D Common Stock 2723 I By 401(k) Option (right to buy) 14.74 2023-08-03 4 M 0 60000 0 D 2017-09-22 2023-09-21 Common Stock 60000 60000 D Option (right to buy) 14.74 2023-08-04 4 M 0 60000 0 D 2017-09-22 2023-09-21 Common Stock 60000 0 D Includes 190,763 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.50 to $20.60. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 2, 2023. The option, representing the right to purchase a total of 120,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 22, 2020. /s/ Nina Ayer, Attorney in Fact 2023-08-07